These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8983878)

  • 41. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
    Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
    Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyunsaturated fat in the diet may improve intestinal function in patients with Crohn's disease.
    French MA; Parrott AM; Kielo ES; Rajotte RV; Wang LC; Thomson AB; Clandinin MT
    Biochim Biophys Acta; 1997 May; 1360(3):262-70. PubMed ID: 9197469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
    Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absorption of prednisolone in patients with Crohn's disease.
    Shaffer JA; Williams SE; Turnberg LA; Houston JB; Rowland M
    Gut; 1983 Mar; 24(3):182-6. PubMed ID: 6826099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure.
    Edlund H; Grisic AM; Steenholdt C; Ainsworth MA; Brynskov J; Huisinga W; Kloft C
    Ther Drug Monit; 2019 Apr; 41(2):235-242. PubMed ID: 30883516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.
    Stack WA; Mann SD; Roy AJ; Heath P; Sopwith M; Freeman J; Holmes G; Long R; Forbes A; Kamm MA
    Lancet; 1997 Feb; 349(9051):521-4. PubMed ID: 9048788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease.
    Sigall-Boneh R; Pfeffer-Gik T; Segal I; Zangen T; Boaz M; Levine A
    Inflamm Bowel Dis; 2014 Aug; 20(8):1353-60. PubMed ID: 24983973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial.
    Riordan AM; Hunter JO; Cowan RE; Crampton JR; Davidson AR; Dickinson RJ; Dronfield MW; Fellows IW; Hishon S; Kerrigan GN
    Lancet; 1993 Nov; 342(8880):1131-4. PubMed ID: 7901473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.
    Tanner AR; Halliday JW; Powell LW
    Digestion; 1981; 21(6):310-5. PubMed ID: 7250552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of factors relevant to primary non-response to infliximab treatment in patients with Crohn's disease].
    Tian XL; Zhou LY; Gu F; Song ZQ; Li J; Lü YM
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(10):744-749. PubMed ID: 30884627
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma propranolol concentrations and the erythrocyte sedimentation rate.
    Schneider RE; Bishop H; Hawkins CF
    Br J Clin Pharmacol; 1979 Jul; 8(1):43-7. PubMed ID: 552296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease.
    Kuroki F; Iida M; Matsumoto T; Aoyagi K; Kanamoto K; Fujishima M
    Dig Dis Sci; 1997 Jun; 42(6):1137-41. PubMed ID: 9201073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
    Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune activation and nutritional status in adult Crohn's disease patients.
    Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
    Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.